|
【结 构 式】 
|
【分子编号】35183 【品名】(4aR,4bS,6aS,7S,9aS,9bS,10S,11aR)-1-(2,4-dimethoxybenzyl)-7-[(1R)-1-hydroxyethyl]-4a,6a,10-trimethylhexadecahydro-2H-indeno[5,4-f]quinolin-2-one 【CA登记号】 |
【 分 子 式 】C30H45NO4 【 分 子 量 】483.69164 【元素组成】C 74.5% H 9.38% N 2.9% O 13.23% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(XII)After hydrogenation of the enamine double bond of (XI) to give (XII), alkylation of the hydroxyl group of (XII) in the presence of KH provided the methyl ether (XIII). The dimethoxybenzyl protecting group of (XIII) was then cleaved with trifluoroacetic acid to give (XIV). This was finally dehydrogenated to the title compound employing DDQ or (PhSeO)2O as the oxidant reagents.
| 【1】 Harris, G.S.; Tolman, R.L.; Ellsworth, K.P.; Rasmusson, G.H.; Chang, B.C.; Patel, G.F.; Bakshi, R.K.; 3-Oxo-4aza-5alpha-7beta-methylpregnan-20-ethers as inhibitors of human type 1 5alpha-reductase: Synthesis and structure-activity relationship. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 226. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (XI) | 35182 | (4aR,4bS,6aS,7S,9aS,9bS,10R)-1-(2,4-dimethoxybenzyl)-7-[(1R)-1-hydroxyethyl]-4a,6a,10-trimethyl-1,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-2H-indeno[5,4-f]quinolin-2-one | C30H43NO4 | 详情 | 详情 | |
| (XII) | 35183 | (4aR,4bS,6aS,7S,9aS,9bS,10S,11aR)-1-(2,4-dimethoxybenzyl)-7-[(1R)-1-hydroxyethyl]-4a,6a,10-trimethylhexadecahydro-2H-indeno[5,4-f]quinolin-2-one | C30H45NO4 | 详情 | 详情 | |
| (XIII) | 35184 | (4aR,4bS,6aS,7S,9aS,9bS,10S,11aR)-1-(2,4-dimethoxybenzyl)-7-[(1R)-1-methoxyethyl]-4a,6a,10-trimethylhexadecahydro-2H-indeno[5,4-f]quinolin-2-one | C31H47NO4 | 详情 | 详情 | |
| (XIV) | 35185 | (4aR,4bS,6aS,7S,9aS,9bS,10S,11aR)-7-[(1R)-1-methoxyethyl]-4a,6a,10-trimethylhexadecahydro-2H-indeno[5,4-f]quinolin-2-one | C22H37NO2 | 详情 | 详情 |
Extended Information